Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer

The efficacy of cancer immunotherapy may be improved by increasing the number of circulating tumor-reactive T cells. The bone marrow is a priming site and reservoir for such T cells. The characteristics of bone marrow-derived tumor-reactive T cells are poorly understood in patients with non-small-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Safi, Seyer, Yamauchi, Yoshikane, Stamova, Slava, Rathinasamy, Anchana, op den Winkel, Jan, Jünger, Simone, Bucur, Mariana, Umansky, Ludmilla, Warth, Arne, Herpel, Esther, Eichhorn, Martin, Winter, Hauke, Hoffmann, Hans, Beckhove, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844373/
https://www.ncbi.nlm.nih.gov/pubmed/31741774
http://dx.doi.org/10.1080/2162402X.2019.1671762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844373/
https://www.ncbi.nlm.nih.gov/pubmed/31741774
http://dx.doi.org/10.1080/2162402X.2019.1671762

Ejemplares similares